Life Expectancy at Birth for People with Serious Mental Illness and Other Major Disorders from a Secondary Mental Health Care Case Register in London
Open accessThe DOI matches its Crossref record; 43 of the 44 references it cites were found in a registry or an index; 11 of the 26 sources its claims cite were checked for support.
Abstract
Compared to national figures, all disorders were associated with substantially lower life expectancy: 8.0 to 14.6 life years lost for men and 9.8 to 17.5 life years lost for women. Highest reductions were found for men with schizophrenia (14.6 years lost) and women with schizoaffective disorders (17.5 years lost).
Overview
CoChat Summary
TL;DR
Using a large South London mental health case register linked to national mortality data, the paper estimates markedly reduced life expectancy at birth for people with serious mental illness and related disorders. The largest losses were 14.6 years for men with schizophrenia and 17.5 years for women with schizoaffective disorder.
Key findings
- Among 31,719 eligible people aged 15+ with SMI, 1,370 died during 2007–09.
- Compared with national figures, all disorders were associated with 8.0 to 14.6 life years lost for men and 9.8 to 17.5 life years lost for women.
- The greatest reductions were 14.6 years lost for men with schizophrenia and 17.5 years lost for women with schizoaffective disorders.
- In the analyzed sample, life expectancy at birth ranged from 62.8 years (men with schizophrenia) to 69.4 years (men with schizoaffective disorder), and from 64.1 years (women with schizoaffective disorder) to 74.4 years (women with depressive disorders).
Methods
- Retrospective register-based analysis using the SLAM Case Register Interactive Search (CRIS), a secondary mental health care database covering southeast London.
- Included people diagnosed before end-2009 with schizophrenia, schizoaffective disorder, bipolar disorder, substance use disorder, depressive episode, or recurrent depressive disorder and under active review during 2007–09; final analytic sample was 31,719 people aged 15+.
- Estimated life expectancy at birth by gender and diagnosis using national mortality returns (2007–09) and Chiang’s abridged life table method in 5-year age groups.
Limitations
- The authors state that the secondary healthcare setting may limit generalizability, especially for substance use disorders and depressive disorders, because register cases are likely a more severe and unrepresentative subset of community cases.
- Diagnostic categories overlapped, but the study analyzed disorders separately; the paper says comorbidity between SMI and substance use disorders should not be assumed to be captured because source data reflected primary diagnoses rather than co-occurrence.
- Evident from the text: the study uses administrative/register data and compares to national norms, so it cannot fully disentangle causal pathways or all confounding factors behind the mortality differences.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
7 Valid · 1 Not valid · 10 Not checked · 19 Own results and interpretations
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“Despite healthcare improvements, there has been little evidence of benefit on life expectancy in people with SMI [1], [20], [21]”
§ Life Expectancy at Birth for People with Serious Mental Illness and Other Major Disorders from a Secondary Mental Health Care Case Register in London > Introduction Concerns about premature mortality among people with mental disorders have been increasing [1]–[6]. Higher general and specific causes of mortality in all or specific age groups have been identified for people with serious mental illnesses (SMI, which might include schizophrenia, schizoaffective disorder, bipolar disorder, and depressive psychosis) in a range of settings [1], [2], [7]–[11], although most report relative risks or rates of mortality rather than life expectancy – which is arguably a more important index for shaping policy since it takes premature mortality into account and has been widely used for other risk exposures such as smoking, diabetes, obesity, ethnicity and socioeconomic status [12]–[17]. Of the few studies to measure this outcome, clients with SMI from public mental health agencies in eight US states from 1997 to 2000 were found to have lower life expectancies of 13 to more than 30 years compared to the general population (depending on the year and state) [2], and a loss of 8.8 life years (14.1 years for men and 5.7 years for women) was estimated in a comparison between people treated for SMI and the general population in Massachusetts, US [1]. A Swedish study using a nationwide hospital discharge registry reported substantial gaps in life expectancy at age 30 for main mental disorder categories compared to the general population, particularly for functional psychosis other than schizophrenia / affective psychosis (15.9 years lost), substance abuse (15.6 years lost), and organic psychosis (14.8 years lost) among men and organic psychosis (22.6 years lost), mental retardation (14.7 years lost), and substance abuse (18.8 years lost) among women [18]. Preliminary strategies for preventing premature deaths among people with SMI have been suggested, emphasizing the management of suicide risk and physical illness, minimum polypharmacy, and improvement of accessibility to physical health care [19]. Despite healthcare improvements, there has been little evidence of benefit on life expectancy in people with SMI [1], [20], [21], and further research is urgently required [22]. We reported excess mortality for people with diagnoses of SMI, as well as for depressive and substance use disorders, drawing on data from the South London and Maudsley NHS Foundation Trust Biomedical Research Centre (SLAM BRC) Case Register, which covers comprehensive secondary mental healthcare provision to a large geographically defined community, by standardized mortality ratios (SMRs) [23]. Nonetheless, equal weighting is used for each age group in the calculation of SMRs, which is insufficient for highlighting the impact of premature mortality among younger age groups in the study cohort.
What the sources say
- Not checked — no full text of the sourcecites [1] BP Dembling, 1999, Life expectancy and causes of death in a population treated for serious mental illness., Psychiatr Serv source
- Supportedcites [20] R Gray, 2009, Physical health and severe mental illness: if we don't do something about it, who will?, Int J Ment Health Nurs source
The opening discussion states that life expectancy for people with severe mental illness is decreasing, supporting the claim that it has shown little benefit. The discussion of interventions describes improvements in physical-health risk factors but says only a minority of patients receive them. Page numbers are not provided in our copy. (LLM, conf=0.86)
- Not checked — no full text of the sourcecites [21] LA Chwastiak, 2009, The unchanging mortality gap for people with schizophrenia., Lancet source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
Every source the paper cites for this claim was checked and supports it.
In the paper
“However, in a sensitivity analysis of SMR data, the use of London comparators did not meaningfully change findings [23].”
§ Life Expectancy at Birth for People with Serious Mental Illness and Other Major Disorders from a Secondary Mental Health Care Case Register in London > Discussion Using a large secondary mental healthcare database in southeast London linked to national mortality returns, we confirmed substantially shortened life expectancies at birth for all serious mental disorder groups investigated compared to national norms. Largest reductions were found for men with schizophrenia, women with schizoaffective disorders, and both men and women with substance use disorders. In previous analyses of these cohorts, raised standardised mortality ratios (SMRs) had been described [23], although the picture was less dramatic because SMRs reflect less well the impact of premature mortality at earlier life stages. In a US study conducted by the Massachusetts Department of Mental Health from 1989 to 1994, service users with SMI were found to have lost 8.8 years of potential life (14.1 years for men and 5.7 for women) on average compared to the general population, a stronger impact for men and weaker impact for women compared to findings from our sample. However, SMI was not specifically defined in the Massachusetts study other than stating “evidence of serious dysfunction” as an inclusion criterion [1], which might explain the discrepancy. A Swedish analysis of national discharges from 1978–82 reported more complex data on life expectations at given ages. For the lowest age described (30 years), subsequent life expectancy associated with schizophrenia was 7.9 years lower in men and 9.5 years lower in women [18] – i.e. similar to the finding for women in our sample but less strong for men. Further international research is clearly required to compare the potential impacts of SMI on life expectancy in different settings since this may provide clues as to systems of care which may help to maximise this. Mortality in SMI is recognised to be raised and underlying causes may be multiple. As well as our own findings, any psychiatric diagnosis was associated with a 65% higher than expected total mortality in a case register study in a British primary care cohort [30]. In the same setting, a three-fold elevated mortality was found for coronary heart disease in young adults with SMI, and a more than two-fold increased mortality of stroke in all age groups [8]. Long-term antipsychotic use and adverse lifestyle choices (e.g. obesity, smoking, poor diet, illicit drug use, and physical inactivity) are implicated in increased risk of cardiovascular events in these populations [3], [19], [20], [22], [31]–[33] and clearly need higher levels of consideration in order to improve health and survival, as well as the better-known risks of suicide and violent deaths. Because the causal pathways between mental disorder and premature mortality are multiple, and because life years lost as an outcome measures not only the effect of an exposure on risk of mortality but also its differential effect across the age range, it is difficult to interpret with certainty the gender variation in findings – i.e. the strongest effects of schizophrenia in men and schizoaffective disorder in women. Clearly the two disorders overlap substantially at a genetic and biological level. It is possible that the impact of co-occurring affective disorder is stronger in women due to specific biological or social vulnerability. However, against this, there was no difference in the impact of bipolar disorder between men and women and the impact of depressive episode/disorder was stronger in men. Alternative explanations may lie in the clinical practice of assigning diagnoses and gender differences here – for example, if there was preferential inclusion in women of severe personality disorders with transient psychotic episodes within this diagnostic group. Further research is clearly required to clarify this issue. Life expectancy is a commonly used indicator for how longevity may be impaired by specific long-term exposures (e.g. smoking, obesity, ethnicity, and socioeconomic status) or chronic states of ill-health or risk (e.g. diabetes mellitus) [12], [13], [15]–[17], [34], and provides an alternative platform to discriminate the influences of different exposures for the purpose of highlighting premature mortality at younger ages in potentially vulnerable groups [25]. It is therefore primarily a measure of impact and should be seen as complementary to more common studies using measures of effect, such as SMR statistics. As a measure, life expectancy analyses provide an important means of communicating impact on survival to policy makers and lay audiences. This approach also allows the impact of different exposures to be compared in a way which cannot be inferred from SMR outputs. As a case in point, considering the impact of other well-recognised exposures and comparing these with the potential impact of SMI, in a Japanese study of life expectancy from age 40, smoking was the most important predictor of six lifestyle related exposures (smoking, alcohol consumption, walking duration, sleep duration, consumption of green leafy vegetables, and obesity), current smoking being associated with around four to five life years lost for both genders [12], [13]. Considering 2005 life expectancy levels in the USA (75.1 years for men and 80.3 years for women), current and previous smoking was associated with 2.5 years lower life expectancy for men and 1.8 years lower life expectancy for women [17]. For British doctors born in 1900–1930 and followed up for fifty years, continued smoking was associated with around 10 years life lost, compared to lifelong non-smokers [16], and in New Zealand Census records in 1996, the gap in life expectancy between current and never smokers was 7.6 years in men and 6.7 for women [15]. Diabetes was reported to reduce life expectancy at age 15 by 1.3 years for men and 2.0 years for women in Canada [14], and a BMI of 40–45 kg/m2 was associated with a 10 year reduction of life expectancy at age 35 compared to a BMI 22.5–25 kg/m2 [35]. The potential impact of having a serious mental illness (or a substance use disorder or a depressive episode requiring secondary care contact) on life expectancy is therefore at least comparable and at worse substantially higher than effects of individual well-recognised exposures, although clearly the mechanisms through which mental disorders are associated with premature mortality will include the effects of these individual risk factors (for example, smoking behaviour, risk of diabetes, etc.) as well as other factors (such as risk of suicide or accidents and direct effects of mental distress on cardiovascular risk). Excess mortality associated with mental disorders has been demonstrated to be predominantly due to ‘natural’ causes [3], [5], [30], [31], [36]–[38], although mental health service provision is often focused on preventing more rare outcomes of suicide and violent death [39]–[41]. If improving overall survival is to be considered as an alternative priority, much more efforts are clearly required to address the challenges of improving general health in people with mental disorders through medical services, socioeconomic support, and physical health promotion strategies [19]. Strengths of the study described include the large sample size and nationwide coverage of mortality, as well as the context of complete electronic clinical records. Potential limitations include the secondary healthcare setting; this should present no problem for high penetrance disorders, such as schizophrenia and bipolar disorder, where most cases will have received secondary care input. However, findings for substance use disorders and depressive disorders should be viewed with circumspection since those appearing on a secondary care register are likely to be an unrepresentative (and probably more severe) subset of community cases. Ultimately, the findings for life expectancy should be taken as referring to people with these mental disorders who had made contact with secondary mental health services within the given time period and are not necessarily applicable to all cases in a given community. Diagnostic categories overlapped, but only a minority (5.7%) of people had received more than one mental disorder diagnosis during the surveillance period. Nevertheless, comorbidity between SMI and substance use disorders should not be assumed to be captured as the source data reflected primary diagnoses rather than co-occurrence. Also we did not attempt to capture co-occurring or changing diagnoses which present potentially complex issues for analysis in a secondary care sample and which we felt were beyond the scope of this initial report. Although SLAM is a major academic as well as clinical centre, mental disorders on the Case Register are likely to be broadly generalizable to other urban settings in the UK (the SLAM catchment covers a range of residence areas from inner city to suburban settings but does not include any rural areas). Life expectancy comparisons of regional data to national norms may be problematic. However, in a sensitivity analysis of SMR data, the use of London comparators did not meaningfully change findings [23]. Also, from administrative data, life expectancy at birth for population of the four catchment area boroughs in 2007–09 (ranging from 76.3–79.5 years for males and 81.1–82.9 years for females), were not substantially different to national estimates [42]. Our results demonstrate the substantial impact of serious mental illness on life expectancy and highlight importance of developing strategies to prevent premature mortality among people with SMI and other major mental disorders. Although the prevention of suicides and violent deaths are likely to be an important component, other causes of excess mortality should not be ignored, including cardiovascular diseases, cancer, and diabetes [3], [4], [7], [8], [22], [31]. Physical health risk assessments and assertive intervention by primary and secondary medical services have been proposed and have resulted in improvements [20], [43]. Continued monitoring of mortality trends in people with mental disorders will be required to evaluate the impact of policy changes as they occur.
What the sources say
- Supportedcites [23] CK Chang, 2010, All-cause mortality among people with serious mental illness (SMI), substance use disorders, and depressive disorders in southeast London: a cohort study., BMC Psychiatry source
The Results report that SMRs standardized using London mortality data were comparable to those using England and Wales data. The Discussion states that this sensitivity analysis did not reveal any meaningful differences. (LLM, conf=0.95)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Excess mortality associated with mental disorders has been demonstrated to be predominantly due to ‘natural’ causes [3], [5], [30], [31], [36]–[38]”
§ Life Expectancy at Birth for People with Serious Mental Illness and Other Major Disorders from a Secondary Mental Health Care Case Register in London > Discussion Using a large secondary mental healthcare database in southeast London linked to national mortality returns, we confirmed substantially shortened life expectancies at birth for all serious mental disorder groups investigated compared to national norms. Largest reductions were found for men with schizophrenia, women with schizoaffective disorders, and both men and women with substance use disorders. In previous analyses of these cohorts, raised standardised mortality ratios (SMRs) had been described [23], although the picture was less dramatic because SMRs reflect less well the impact of premature mortality at earlier life stages. In a US study conducted by the Massachusetts Department of Mental Health from 1989 to 1994, service users with SMI were found to have lost 8.8 years of potential life (14.1 years for men and 5.7 for women) on average compared to the general population, a stronger impact for men and weaker impact for women compared to findings from our sample. However, SMI was not specifically defined in the Massachusetts study other than stating “evidence of serious dysfunction” as an inclusion criterion [1], which might explain the discrepancy. A Swedish analysis of national discharges from 1978–82 reported more complex data on life expectations at given ages. For the lowest age described (30 years), subsequent life expectancy associated with schizophrenia was 7.9 years lower in men and 9.5 years lower in women [18] – i.e. similar to the finding for women in our sample but less strong for men. Further international research is clearly required to compare the potential impacts of SMI on life expectancy in different settings since this may provide clues as to systems of care which may help to maximise this. Mortality in SMI is recognised to be raised and underlying causes may be multiple. As well as our own findings, any psychiatric diagnosis was associated with a 65% higher than expected total mortality in a case register study in a British primary care cohort [30]. In the same setting, a three-fold elevated mortality was found for coronary heart disease in young adults with SMI, and a more than two-fold increased mortality of stroke in all age groups [8]. Long-term antipsychotic use and adverse lifestyle choices (e.g. obesity, smoking, poor diet, illicit drug use, and physical inactivity) are implicated in increased risk of cardiovascular events in these populations [3], [19], [20], [22], [31]–[33] and clearly need higher levels of consideration in order to improve health and survival, as well as the better-known risks of suicide and violent deaths. Because the causal pathways between mental disorder and premature mortality are multiple, and because life years lost as an outcome measures not only the effect of an exposure on risk of mortality but also its differential effect across the age range, it is difficult to interpret with certainty the gender variation in findings – i.e. the strongest effects of schizophrenia in men and schizoaffective disorder in women. Clearly the two disorders overlap substantially at a genetic and biological level. It is possible that the impact of co-occurring affective disorder is stronger in women due to specific biological or social vulnerability. However, against this, there was no difference in the impact of bipolar disorder between men and women and the impact of depressive episode/disorder was stronger in men. Alternative explanations may lie in the clinical practice of assigning diagnoses and gender differences here – for example, if there was preferential inclusion in women of severe personality disorders with transient psychotic episodes within this diagnostic group. Further research is clearly required to clarify this issue. Life expectancy is a commonly used indicator for how longevity may be impaired by specific long-term exposures (e.g. smoking, obesity, ethnicity, and socioeconomic status) or chronic states of ill-health or risk (e.g. diabetes mellitus) [12], [13], [15]–[17], [34], and provides an alternative platform to discriminate the influences of different exposures for the purpose of highlighting premature mortality at younger ages in potentially vulnerable groups [25]. It is therefore primarily a measure of impact and should be seen as complementary to more common studies using measures of effect, such as SMR statistics. As a measure, life expectancy analyses provide an important means of communicating impact on survival to policy makers and lay audiences. This approach also allows the impact of different exposures to be compared in a way which cannot be inferred from SMR outputs. As a case in point, considering the impact of other well-recognised exposures and comparing these with the potential impact of SMI, in a Japanese study of life expectancy from age 40, smoking was the most important predictor of six lifestyle related exposures (smoking, alcohol consumption, walking duration, sleep duration, consumption of green leafy vegetables, and obesity), current smoking being associated with around four to five life years lost for both genders [12], [13]. Considering 2005 life expectancy levels in the USA (75.1 years for men and 80.3 years for women), current and previous smoking was associated with 2.5 years lower life expectancy for men and 1.8 years lower life expectancy for women [17]. For British doctors born in 1900–1930 and followed up for fifty years, continued smoking was associated with around 10 years life lost, compared to lifelong non-smokers [16], and in New Zealand Census records in 1996, the gap in life expectancy between current and never smokers was 7.6 years in men and 6.7 for women [15]. Diabetes was reported to reduce life expectancy at age 15 by 1.3 years for men and 2.0 years for women in Canada [14], and a BMI of 40–45 kg/m2 was associated with a 10 year reduction of life expectancy at age 35 compared to a BMI 22.5–25 kg/m2 [35]. The potential impact of having a serious mental illness (or a substance use disorder or a depressive episode requiring secondary care contact) on life expectancy is therefore at least comparable and at worse substantially higher than effects of individual well-recognised exposures, although clearly the mechanisms through which mental disorders are associated with premature mortality will include the effects of these individual risk factors (for example, smoking behaviour, risk of diabetes, etc.) as well as other factors (such as risk of suicide or accidents and direct effects of mental distress on cardiovascular risk). Excess mortality associated with mental disorders has been demonstrated to be predominantly due to ‘natural’ causes [3], [5], [30], [31], [36]–[38], although mental health service provision is often focused on preventing more rare outcomes of suicide and violent death [39]–[41]. If improving overall survival is to be considered as an alternative priority, much more efforts are clearly required to address the challenges of improving general health in people with mental disorders through medical services, socioeconomic support, and physical health promotion strategies [19]. Strengths of the study described include the large sample size and nationwide coverage of mortality, as well as the context of complete electronic clinical records. Potential limitations include the secondary healthcare setting; this should present no problem for high penetrance disorders, such as schizophrenia and bipolar disorder, where most cases will have received secondary care input. However, findings for substance use disorders and depressive disorders should be viewed with circumspection since those appearing on a secondary care register are likely to be an unrepresentative (and probably more severe) subset of community cases. Ultimately, the findings for life expectancy should be taken as referring to people with these mental disorders who had made contact with secondary mental health services within the given time period and are not necessarily applicable to all cases in a given community. Diagnostic categories overlapped, but only a minority (5.7%) of people had received more than one mental disorder diagnosis during the surveillance period. Nevertheless, comorbidity between SMI and substance use disorders should not be assumed to be captured as the source data reflected primary diagnoses rather than co-occurrence. Also we did not attempt to capture co-occurring or changing diagnoses which present potentially complex issues for analysis in a secondary care sample and which we felt were beyond the scope of this initial report. Although SLAM is a major academic as well as clinical centre, mental disorders on the Case Register are likely to be broadly generalizable to other urban settings in the UK (the SLAM catchment covers a range of residence areas from inner city to suburban settings but does not include any rural areas). Life expectancy comparisons of regional data to national norms may be problematic. However, in a sensitivity analysis of SMR data, the use of London comparators did not meaningfully change findings [23]. Also, from administrative data, life expectancy at birth for population of the four catchment area boroughs in 2007–09 (ranging from 76.3–79.5 years for males and 81.1–82.9 years for females), were not substantially different to national estimates [42]. Our results demonstrate the substantial impact of serious mental illness on life expectancy and highlight importance of developing strategies to prevent premature mortality among people with SMI and other major mental disorders. Although the prevention of suicides and violent deaths are likely to be an important component, other causes of excess mortality should not be ignored, including cardiovascular diseases, cancer, and diabetes [3], [4], [7], [8], [22], [31]. Physical health risk assessments and assertive intervention by primary and secondary medical services have been proposed and have resulted in improvements [20], [43]. Continued monitoring of mortality trends in people with mental disorders will be required to evaluate the impact of policy changes as they occur.
What the sources say
- Supportedcites [3] A Fagiolini, 2009, The effects of undertreated chronic medical illnesses in patients with severe mental disorders., J Clin Psychiatry source
The Cardiovascular Disease section reports that approximately 59% of excess deaths in a meta-analysis of patients with schizophrenia were attributed to natural causes. The FOR CLINICAL USE section also reports that most excess deaths in a study of patients with bipolar disorder were due to natural causes. These findings support the cited background statement, particularly for the severe mental disorders the paper discusses. (LLM, conf=0.88)
- Partly supportedcites [5] S Brown, 2000, Causes of the excess mortality of schizophrenia., Br J Psychiatry sourceExperimental — accuracy not yet measured
The Natural cause mortality section reports that natural causes accounted for 63% of excess mortality, and Overall mortality says about two-thirds of extra deaths were from natural causes. The study concerns people with schizophrenia; it does not establish the same predominance across mental disorders generally. Page numbers are not provided in the supplied passages. (LLM, conf=0.86)
- Not checked — no full text of the sourcecites [30] DN Baxter, 1996, The mortality experience of individuals on the Salford Psychiatric Case Register. I. All-cause mortality., Br J Psychiatry source
boostedstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Long-term antipsychotic use and adverse lifestyle choices (e.g. obesity, smoking, poor diet, illicit drug use, and physical inactivity) are implicated in increased risk of cardiovascular events in these populations [3], [19], [20], [22], [31]–[33]”
§ Life Expectancy at Birth for People with Serious Mental Illness and Other Major Disorders from a Secondary Mental Health Care Case Register in London > Discussion Using a large secondary mental healthcare database in southeast London linked to national mortality returns, we confirmed substantially shortened life expectancies at birth for all serious mental disorder groups investigated compared to national norms. Largest reductions were found for men with schizophrenia, women with schizoaffective disorders, and both men and women with substance use disorders. In previous analyses of these cohorts, raised standardised mortality ratios (SMRs) had been described [23], although the picture was less dramatic because SMRs reflect less well the impact of premature mortality at earlier life stages. In a US study conducted by the Massachusetts Department of Mental Health from 1989 to 1994, service users with SMI were found to have lost 8.8 years of potential life (14.1 years for men and 5.7 for women) on average compared to the general population, a stronger impact for men and weaker impact for women compared to findings from our sample. However, SMI was not specifically defined in the Massachusetts study other than stating “evidence of serious dysfunction” as an inclusion criterion [1], which might explain the discrepancy. A Swedish analysis of national discharges from 1978–82 reported more complex data on life expectations at given ages. For the lowest age described (30 years), subsequent life expectancy associated with schizophrenia was 7.9 years lower in men and 9.5 years lower in women [18] – i.e. similar to the finding for women in our sample but less strong for men. Further international research is clearly required to compare the potential impacts of SMI on life expectancy in different settings since this may provide clues as to systems of care which may help to maximise this. Mortality in SMI is recognised to be raised and underlying causes may be multiple. As well as our own findings, any psychiatric diagnosis was associated with a 65% higher than expected total mortality in a case register study in a British primary care cohort [30]. In the same setting, a three-fold elevated mortality was found for coronary heart disease in young adults with SMI, and a more than two-fold increased mortality of stroke in all age groups [8]. Long-term antipsychotic use and adverse lifestyle choices (e.g. obesity, smoking, poor diet, illicit drug use, and physical inactivity) are implicated in increased risk of cardiovascular events in these populations [3], [19], [20], [22], [31]–[33] and clearly need higher levels of consideration in order to improve health and survival, as well as the better-known risks of suicide and violent deaths. Because the causal pathways between mental disorder and premature mortality are multiple, and because life years lost as an outcome measures not only the effect of an exposure on risk of mortality but also its differential effect across the age range, it is difficult to interpret with certainty the gender variation in findings – i.e. the strongest effects of schizophrenia in men and schizoaffective disorder in women. Clearly the two disorders overlap substantially at a genetic and biological level. It is possible that the impact of co-occurring affective disorder is stronger in women due to specific biological or social vulnerability. However, against this, there was no difference in the impact of bipolar disorder between men and women and the impact of depressive episode/disorder was stronger in men. Alternative explanations may lie in the clinical practice of assigning diagnoses and gender differences here – for example, if there was preferential inclusion in women of severe personality disorders with transient psychotic episodes within this diagnostic group. Further research is clearly required to clarify this issue. Life expectancy is a commonly used indicator for how longevity may be impaired by specific long-term exposures (e.g. smoking, obesity, ethnicity, and socioeconomic status) or chronic states of ill-health or risk (e.g. diabetes mellitus) [12], [13], [15]–[17], [34], and provides an alternative platform to discriminate the influences of different exposures for the purpose of highlighting premature mortality at younger ages in potentially vulnerable groups [25]. It is therefore primarily a measure of impact and should be seen as complementary to more common studies using measures of effect, such as SMR statistics. As a measure, life expectancy analyses provide an important means of communicating impact on survival to policy makers and lay audiences. This approach also allows the impact of different exposures to be compared in a way which cannot be inferred from SMR outputs. As a case in point, considering the impact of other well-recognised exposures and comparing these with the potential impact of SMI, in a Japanese study of life expectancy from age 40, smoking was the most important predictor of six lifestyle related exposures (smoking, alcohol consumption, walking duration, sleep duration, consumption of green leafy vegetables, and obesity), current smoking being associated with around four to five life years lost for both genders [12], [13]. Considering 2005 life expectancy levels in the USA (75.1 years for men and 80.3 years for women), current and previous smoking was associated with 2.5 years lower life expectancy for men and 1.8 years lower life expectancy for women [17]. For British doctors born in 1900–1930 and followed up for fifty years, continued smoking was associated with around 10 years life lost, compared to lifelong non-smokers [16], and in New Zealand Census records in 1996, the gap in life expectancy between current and never smokers was 7.6 years in men and 6.7 for women [15]. Diabetes was reported to reduce life expectancy at age 15 by 1.3 years for men and 2.0 years for women in Canada [14], and a BMI of 40–45 kg/m2 was associated with a 10 year reduction of life expectancy at age 35 compared to a BMI 22.5–25 kg/m2 [35]. The potential impact of having a serious mental illness (or a substance use disorder or a depressive episode requiring secondary care contact) on life expectancy is therefore at least comparable and at worse substantially higher than effects of individual well-recognised exposures, although clearly the mechanisms through which mental disorders are associated with premature mortality will include the effects of these individual risk factors (for example, smoking behaviour, risk of diabetes, etc.) as well as other factors (such as risk of suicide or accidents and direct effects of mental distress on cardiovascular risk). Excess mortality associated with mental disorders has been demonstrated to be predominantly due to ‘natural’ causes [3], [5], [30], [31], [36]–[38], although mental health service provision is often focused on preventing more rare outcomes of suicide and violent death [39]–[41]. If improving overall survival is to be considered as an alternative priority, much more efforts are clearly required to address the challenges of improving general health in people with mental disorders through medical services, socioeconomic support, and physical health promotion strategies [19]. Strengths of the study described include the large sample size and nationwide coverage of mortality, as well as the context of complete electronic clinical records. Potential limitations include the secondary healthcare setting; this should present no problem for high penetrance disorders, such as schizophrenia and bipolar disorder, where most cases will have received secondary care input. However, findings for substance use disorders and depressive disorders should be viewed with circumspection since those appearing on a secondary care register are likely to be an unrepresentative (and probably more severe) subset of community cases. Ultimately, the findings for life expectancy should be taken as referring to people with these mental disorders who had made contact with secondary mental health services within the given time period and are not necessarily applicable to all cases in a given community. Diagnostic categories overlapped, but only a minority (5.7%) of people had received more than one mental disorder diagnosis during the surveillance period. Nevertheless, comorbidity between SMI and substance use disorders should not be assumed to be captured as the source data reflected primary diagnoses rather than co-occurrence. Also we did not attempt to capture co-occurring or changing diagnoses which present potentially complex issues for analysis in a secondary care sample and which we felt were beyond the scope of this initial report. Although SLAM is a major academic as well as clinical centre, mental disorders on the Case Register are likely to be broadly generalizable to other urban settings in the UK (the SLAM catchment covers a range of residence areas from inner city to suburban settings but does not include any rural areas). Life expectancy comparisons of regional data to national norms may be problematic. However, in a sensitivity analysis of SMR data, the use of London comparators did not meaningfully change findings [23]. Also, from administrative data, life expectancy at birth for population of the four catchment area boroughs in 2007–09 (ranging from 76.3–79.5 years for males and 81.1–82.9 years for females), were not substantially different to national estimates [42]. Our results demonstrate the substantial impact of serious mental illness on life expectancy and highlight importance of developing strategies to prevent premature mortality among people with SMI and other major mental disorders. Although the prevention of suicides and violent deaths are likely to be an important component, other causes of excess mortality should not be ignored, including cardiovascular diseases, cancer, and diabetes [3], [4], [7], [8], [22], [31]. Physical health risk assessments and assertive intervention by primary and secondary medical services have been proposed and have resulted in improvements [20], [43]. Continued monitoring of mortality trends in people with mental disorders will be required to evaluate the impact of policy changes as they occur.
What the sources say
- Partly supportedcites [3] A Fagiolini, 2009, The effects of undertreated chronic medical illnesses in patients with severe mental disorders., J Clin Psychiatry sourceExperimental — accuracy not yet measured
The Medication Side Effects section says atypical antipsychotics increase the likelihood of cardiovascular disease, and the lifestyle discussion links inactivity, poor diet, and smoking to coronary heart disease. Our copy does not establish a risk specifically from long-term antipsychotic use or address illicit drug use as a cardiovascular risk factor; it discusses cardiovascular disease rather than cardiovascular events specifically. Page numbers were not available in our copy. (LLM, conf=0.86)
- Not checked — no full text of the sourcecites [19] P Auquier, 2006, Mortality in schizophrenia., Pharmacoepidemiol Drug Saf source
- Partly supportedcites [20] R Gray, 2009, Physical health and severe mental illness: if we don't do something about it, who will?, Int J Ment Health Nurs sourceExperimental — accuracy not yet measured
In “Why then do our patients die?” (page not provided), Gray identifies obesity, smoking, lack of exercise and poor diet as prevalent lifestyle risks in people with severe mental illness, and says some prescribed medications increase cardiometabolic disease risk. The passage does not specify long-term antipsychotic use or link illicit drug use to cardiovascular events; it mentions drug misuse only as another influence on health. (LLM, conf=0.85)
plainstates a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“All the life expectancies at birth for specific mental disorders were significantly different between genders based on their 95% confidence intervals.”
§ Life Expectancy at Birth for People with Serious Mental Illness and Other Major Disorders from a Secondary Mental Health Care Case Register in London > Results
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on 2 assumptions not shown here.
6 more claims
Create a free account to see all 37 claims and every source verdict.
- It may state two separate claims as one. 21
- Probably not a substantial claim. 11
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“people with mental health disorders have a life expectancy eight years less than the general population”
From Change in mental health after smoking cessation: systematic review and meta-analysis (2014) · cites this paper as [25]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The reductions of life expectancy among persons with bipolar disorder seem to be slightly smaller: approximately 10 years in a study from London [43], and 13 years in a Danish study made on data similar to the Danish data used in Table 3 [44].”
From Life expectancy and death by diseases of the circulatory system in patients with bipolar disorder or schizophrenia in the Nordic countries. (2013) · cites this paper as [43]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“This mortality gap translates to a 10-20 year shortened life expectancy 3,4”
From Diabetes mellitus in people with schizophrenia, bipolar disorder and major depressive disorder: a systematic review and large scale meta‐analysis (2016) · cites this paper as [3]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“This mortality gap translates into a 10-20 year shortened life expectancy (3,4) and appears to be widening (5).”
From Risk of metabolic syndrome and its components in people with schizophrenia and related psychotic disorders, bipolar disorder and major depressive disorder: a systematic review and meta‐analysis (2015) · cites this paper as [3]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“A recent study from the United Kingdom (Chang et al. 2011) found that life expectancy was reduced by 14.6 years among persons with schizophrenia.”
From Excess early mortality in schizophrenia. (2014) · cites this paper as Chang et al. 2011
Experimental — accuracy not yet measured
Citations
Cites
Mortality in relation to smoking: 40 years' observations on male British doctors
Doll, R., Peto, R., Wheatley, K., Gray, R., & Sutherland, I. (1994) · BMJ · doi:10.1136/bmj.309.6959.901 · Cited by 5,932
Prospective Studies Collaboration (2009) · The Lancet · doi:10.1016/s0140-6736(09)60318-4 · Cited by 4,807
Mortality in relation to smoking: 50 years' observations on male British doctors
Doll, R., Peto, R., Boreham, J., & Sutherland, I. (2004) · BMJ · doi:10.1136/bmj.38142.554479.ae · Cited by 2,920 · cited 1×
“. For British doctors born in 1900–1930 and followed up for fifty years, continued smoking was associated with around 10 years life lost, compared to lifelong non-smokers”
BackgroundSchizophrenia: A Concise Overview of Incidence, Prevalence, and Mortality
McGrath, J., Saha, S., Chant, D., & Welham, J. (2008) · Epidemiologic Reviews · doi:10.1093/epirev/mxn001 · Cited by 2,280
Saha, S., Chant, D., & McGrath, J. (2007) · Archives of General Psychiatry · doi:10.1001/archpsyc.64.10.1123 · Cited by 2,065
Excess mortality of mental disorder
Harris, C., & Barraclough, B. (1998) · British Journal of Psychiatry · doi:10.1192/bjp.173.1.11 · Cited by 1,881 · cited 1×
“Although the prevention of suicides and violent deaths are likely to be an important component, other causes of excess mortality should not be ignored, including cardiovascular diseases, cancer, and diabetes [3,4,7,8,22,31].”
Background(2006) · Europe PMC (PubMed Central) · Cited by 1,299
Causes of the excess mortality of schizophrenia
Brown, S., Inskip, H., & Barraclough, B. (2000) · British Journal of Psychiatry · doi:10.1192/bjp.177.3.212 · Cited by 1,087 · cited 2×
“Excess mortality associated with mental disorders has been demonstrated to be predominantly due to ‘natural’ causes [3,5,30,31,36–38], although mental health service provision is often focused on preventing more rare outcomes of suicide and violent death [39–41].”
BackgroundDe Hert, M., Dekker, J. M., Wood, D., Kahl, K. G., Holt, R. I. G., & Möller, H.-J. (2009) · European Psychiatry · doi:10.1016/j.eurpsy.2009.01.005 · Cited by 951
The unhealthy lifestyle of people with schizophrenia
BROWN, S., BIRTWISTLE, J., ROE, L., & THOMPSON, C. (1999) · Psychological Medicine · doi:10.1017/s0033291798008186 · Cited by 874 · cited 1×
“obesity, smoking, poor diet, illicit drug use, and physical inactivity) are implicated in increased risk of cardiovascular events in these populations [3,19,20,22,31–33] and clearly need higher levels of consideration in order to improve health and survival, as well as the better-known risks of suicide and violent dea…”
Background
Cited by
Risks of all-cause and suicide mortality in mental disorders: a meta-review
Chesney, E., Goodwin, G. M., & Fazel, S. (2014) · World Psychiatry · doi:10.1002/wps.20128 · Cited by 2,115
“Depressive episode/recurrent depressive disorder (43) 10.”
BackgroundCorrell, C. U., Solmi, M., Veronese, N., Bortolato, B., Rosson, S., Santonastaso, P., Thapa‐Chhetri, N., Fornaro, M., Gallicchio, D., Collantoni, E., et al. (2017) · World Psychiatry · doi:10.1002/wps.20420 · Cited by 1,729
Hjorthøj, C., Stürup, A. E., McGrath, J. J., & Nordentoft, M. (2017) · The Lancet Psychiatry · doi:10.1016/s2215-0366(17)30078-0 · Cited by 1,304
Vancampfort, D., Stubbs, B., Mitchell, A. J., De Hert, M., Wampers, M., Ward, P. B., Rosenbaum, S., & Correll, C. U. (2015) · World Psychiatry · doi:10.1002/wps.20252 · Cited by 1,271
Change in mental health after smoking cessation: systematic review and meta-analysis
Taylor, G., McNeill, A., Girling, A., Farley, A., Lindson-Hawley, N., & Aveyard, P. (2014) · BMJ · doi:10.1136/bmj.g1151 · Cited by 1,039
Knaak, S., Mantler, E., & Szeto, A. (2017) · Healthcare Management Forum · doi:10.1177/0840470416679413 · Cited by 1,031
“Studies also demonstrate that persons with mental illness histories receive poorer quality care for their physical health problems.(29,35,37,41,42) This is believed to occur largely through a process of diagnostic and treatment overshadowing, whereby physical symptoms are misattributed to a patient’s mental illness, c…”
BackgroundExcess early mortality in schizophrenia.
Laursen, T. M., Nordentoft, M., & Mortensen, P. B. (2014) · Annual Review of Clinical Psychology · doi:10.1146/annurev-clinpsy-032813-153657 · Cited by 913
Patel, V., Chisholm, D., Parikh, R., Charlson, F. J., Degenhardt, L., Dua, T., Ferrari, A. J., Hyman, S., Laxminarayan, R., Levin, C., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(15)00390-6 · Cited by 889
Pescosolido, B. A., & Martin, J. K. (2015) · Annual Review of Sociology · doi:10.1146/annurev-soc-071312-145702 · Cited by 862
Lawrence, D., Hancock, K. J., & Kisely, S. (2013) · BMJ · doi:10.1136/bmj.f2539 · Cited by 819
Vancampfort, D., Correll, C. U., Galling, B., Probst, M., De Hert, M., Ward, P. B., Rosenbaum, S., Gaughran, F., Lally, J., & Stubbs, B. (2016) · World Psychiatry · doi:10.1002/wps.20309 · Cited by 659
Wootton, R. E., Richmond, R. C., Stuijfzand, B. G., Lawn, R. B., Sallis, H. M., Taylor, G. M. J., Hemani, G., Jones, H. J., Zammit, S., Davey Smith, G., et al. (2020) · Psychological Medicine · doi:10.1017/s0033291719002678 · Cited by 587
“Individuals with mental health conditions smoke more heavily (Coulthard et al., 2002) and experience up to 18 years reduced life expectancy compared with the general population (Chang et al., 2011; Royal College of Physicians, 2013).”
BackgroundLife expectancy and cardiovascular mortality in persons with schizophrenia
Laursen, T. M., Munk-Olsen, T., & Vestergaard, M. (2012) · Current Opinion in Psychiatry · doi:10.1097/yco.0b013e32835035ca · Cited by 518
Perera, G., Broadbent, M., Callard, F., Chang, C.-K., Downs, J., Dutta, R., Fernandes, A., Hayes, R. D., Henderson, M., Jackson, R., et al. (2016) · BMJ Open · doi:10.1136/bmjopen-2015-008721 · Cited by 492
Self-citationMortality gap for people with bipolar disorder and schizophrenia: UK-based cohort study 2000–2014
Hayes, J. F., Marston, L., Walters, K., King, M. B., & Osborn, D. P. J. (2017) · British Journal of Psychiatry · doi:10.1192/bjp.bp.117.202606 · Cited by 451
Can bipolar disorder be viewed as a multi-system inflammatory disease?
Leboyer, M., Soreca, I., Scott, J., Frye, M., Henry, C., Tamouza, R., & Kupfer, D. J. (2012) · Journal of Affective Disorders · doi:10.1016/j.jad.2011.12.049 · Cited by 417
“Life expectancy at birth, an indicator of all-cause mortality, has been estimated roughly 10 and 11 years shorter for men and women with bipolar disorder compared to the non-mentally ill general population (Chang et al., 2011).”
BackgroundTechnological innovations in mental healthcare: harnessing the digital revolution
Hollis, C., Morriss, R., Martin, J., Amani, S., Cotton, R., Denis, M., & Lewis, S. (2015) · British Journal of Psychiatry · doi:10.1192/bjp.bp.113.142612 · Cited by 375
“The system has been used in many studies, an example being the extraction of data from a single NHS Trust to show substantially increased mortality in people with serious mental illness [9].”
MethodCorrell, C. U., Robinson, D. G., Schooler, N. R., Brunette, M. F., Mueser, K. T., Rosenheck, R. A., Marcy, P., Addington, J., Estroff, S. E., Robinson, J., et al. (2014) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2014.1314 · Cited by 384
Cancer-Related Mortality in People With Mental Illness
Kisely, S., Crowe, E., & Lawrence, D. (2013) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2013.278 · Cited by 362
“One explanation is that cancer goes unrecognized especially among those with severe mental illness, although this may apply less to cancer than other physical diseases.(4,37-39) For instance, postmortem data from Denmark, where autopsies are common, indicate that postmortem diagnoses of previously unrecognized cancer…”
BackgroundLaursen, T. M., Wahlbeck, K., Hällgren, J., Westman, J., Ösby, U., Alinaghizadeh, H., Gissler, M., & Nordentoft, M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0067133 · Cited by 313
“The reductions of life expectancy among persons with bipolar disorder seem to be slightly smaller: approximately 10 years in a study from London [43], and 13 years in a Danish study made on data similar to the Danish data used in Table 3 [44].”
ResultEnsuring mental health care during the SARS-CoV-2 epidemic in France: A narrative review
Chevance, A., Gourion, D., Hoertel, N., Llorca, P.-M., Thomas, P., Bocher, R., Moro, M.-R., Laprévote, V., Benyamina, A., Fossati, P., et al. (2020) · L'Encéphale · doi:10.1016/j.encep.2020.04.005 · Cited by 273
“5 grande partie responsable d’une diminution de l’espérance de vie de 10 à 15 ans chez les patients présentant un trouble psychiatrique chronique comparativement à la population générale (14).”
Vermeulen, J. M., van Rooijen, G., van de Kerkhof, M. P. J., Sutterland, A. L., Correll, C. U., & de Haan, L. (2019) · Schizophrenia Bulletin · doi:10.1093/schbul/sby052 · Cited by 246
Depression and violence: a Swedish population study
Fazel, S., Wolf, A., Chang, Z., Larsson, H., Goodwin, G. M., & Lichtenstein, P. (2015) · The Lancet Psychiatry · doi:10.1016/s2215-0366(14)00128-x · Cited by 245
Chan, J. K. N., Correll, C. U., Wong, C. S. M., Chu, R. S. T., Fung, V. S. C., Wong, G. H. S., Lei, J. H. C., & Chang, W. C. (2023) · eClinicalMedicine · doi:10.1016/j.eclinm.2023.102294 · Cited by 233
Integrated Neurobiology of Bipolar Disorder
Maletic, V., & Raison, C. (2014) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2014.00098 · Cited by 226
“Astrocytes become unable to maintain the integrity of the blood–brain barrier and optimal neurovascular coupling (3).”
BackgroundInfluentialThe interface of physical and mental health
Doherty, A. M., & Gaughran, F. (2014) · Social Psychiatry and Psychiatric Epidemiology · doi:10.1007/s00127-014-0847-7 · Cited by 217
Chevance, A., Gourion, D., Hoertel, N., Llorca, P.-M., Thomas, P., Bocher, R., Moro, M.-R., Laprévote, V., Benyamina, A., Fossati, P., et al. (2020) · L'Encéphale · doi:10.1016/j.encep.2020.03.001 · Cited by 218
Life expectancy in bipolar disorder
Kessing, L. V., Vradi, E., & Andersen, P. K. (2015) · Bipolar Disorders · doi:10.1111/bdi.12296 · Cited by 214
“8), in accordance with previous findings based on the case register (19) and with the London study [mean age 43 years for men and 45 years for women (12)].”
BackgroundResultInfluentialSchizophrenia--Time to Commit to Policy Change
Fleischhacker, W. W., Arango, C., Arteel, P., Barnes, T. R. E., Carpenter, W., Duckworth, K., Galderisi, S., Halpern, L., Knapp, M., Marder, S. R., et al. (2014) · Schizophrenia Bulletin · doi:10.1093/schbul/sbu006 · Cited by 214
Sheals, K., Tombor, I., McNeill, A., & Shahab, L. (2016) · Addiction · doi:10.1111/add.13387 · Cited by 204
“People with mental illness or substance use disorders are more likely to be heavier and more dependent smokers [6,7], and their life expectancy is reduced by up to 20 years [8,9], mainly because of smoking [7].”
BackgroundCauses of decreased life expectancy over the life span in bipolar disorder
Kessing, L. V., Vradi, E., McIntyre, R. S., & Andersen, P. K. (2015) · Journal of Affective Disorders · doi:10.1016/j.jad.2015.03.027 · Cited by 200
Fernandes, A. C., Cloete, D., Broadbent, M. T., Hayes, R. D., Chang, C.-K., Jackson, R. G., Roberts, A., Tsang, J., Soncul, M., Liebscher, J., et al. (2013) · BMC Medical Informatics and Decision Making · doi:10.1186/1472-6947-13-71 · Cited by 191
“CRIS has contributed to research on Alzheimer’s disease, severe mental illness and its associations with mortality, early-stage psychosis and other more rare disorders or syndromes [13-20].”
BackgroundSelf-citationJanssen, E. M., McGinty, E. E., Azrin, S. T., Juliano-Bult, D., & Daumit, G. L. (2015) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2015.03.004 · Cited by 194
“Similar to US studies, these national registry-based studies show significantly increased risk for and prevalence of comorbid medical conditions among the populationwith SMI [23–26].”
ResultJohn, A., McGregor, J., Jones, I., Lee, S. C., Walters, J. T. R., Owen, M. J., O'Donovan, M., DelPozo-Banos, M., Berridge, D., & Lloyd, K. (2018) · Schizophrenia Research · doi:10.1016/j.schres.2018.04.009 · Cited by 190
“Studies from secondary care demonstrate the excess mortality persists, but more recent comprehensive studies are essential (Chang et al., 2011).”
Berghs, M., Atkin, K., Graham, H., Hatton, C., & Thomas, C. (2016) · Public Health Research · doi:10.3310/phr04080 · Cited by 186
“One of the reasons for this includes the difficulty of maintaining a healthy lifestyle.(106,107) Smoking cessation raises particular challenges, particularly given that evidence suggests that current interventions are not sensitive to the experiences of those with mental health problems or the ways in which people hav…”
BackgroundCharlson, F. J., Baxter, A. J., Dua, T., Degenhardt, L., Whiteford, H. A., & Vos, T. (2015) · Epidemiology and Psychiatric Sciences · doi:10.1017/s2045796014000687 · Cited by 185
“…Commons Attribution licence (http://creativecommons.org/licenses/by/ 3.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited. expectancy (Chang et al. 2011; Wahlbeck et al. 2011; Crump et al. 2013; Lawrence et al. 2013).”
BackgroundInfluentialSwitching to self-employment can be good for your health
Nikolova, M. (2019) · Journal of Business Venturing · doi:10.1016/j.jbusvent.2018.09.001 · Cited by 172
“openness and extroversion) (Caliendo, Fossen, & Kritikos, 2014) not only influence the self-employment decision, but also health behaviors (Cobb-Clark et al., 2014), and thus health outcomes.”
BackgroundRobson, D., Haddad, M., Gray, R., & Gournay, K. (2013) · International Journal of Mental Health Nursing · doi:10.1111/j.1447-0349.2012.00883.x · Cited by 170
“2007) and their life expectancy can be reduced by up to 17 years (Chang et al. 2011).”
BackgroundRae, B., & Rees, S. (2015) · Journal of Advanced Nursing · doi:10.1111/jan.12675 · Cited by 197
Tobacco-Related Mortality among Persons with Mental Health and Substance Abuse Problems
Bandiera, F. C., Anteneh, B., Le, T. L., Delucchi, K., & Guydish, J. R. (2015) · PLoS ONE · doi:10.1371/journal.pone.0120581 · Cited by 159
“[20–26] Colton and Manderscheid [27] conducted a study in 8 states in the U.”
MethodPatel, R., Wilson, R., Jackson, R., Ball, M., Shetty, H., Broadbent, M., Stewart, R., McGuire, P., & Bhattacharyya, S. (2016) · BMJ Open · doi:10.1136/bmjopen-2015-009888 · Cited by 147
Self-citationGardner-Sood, P., Lally, J., Smith, S., Atakan, Z., Ismail, K., Greenwood, K. E., Keen, A., O'Brien, C., Onagbesan, O., Fung, C., et al. (2015) · Psychological Medicine · doi:10.1017/s0033291715000562 · Cited by 140
“…Attribution licence (http://creativecommons.org/ licenses/by/3.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited. cardiovascular deaths (Saha et al. 2007; Kilbourne et al. 2009; Brown et al. 2010; Chang et al. 2011).”
BackgroundInfluentialChan, J. K. N., Tong, C. C. H. Y., Wong, C. S. M., Chen, E. Y. H., & Chang, W. C. (2022) · The British Journal of Psychiatry · doi:10.1192/bjp.2022.19 · Cited by 177
Areas of uncertainties and unmet needs in bipolar disorders: clinical and research perspectives
Bauer, M., Andreassen, O. A., Geddes, J. R., Kessing, L. V., Lewitzka, U., Schulze, T. G., & Vieta, E. (2018) · The Lancet Psychiatry · doi:10.1016/s2215-0366(18)30253-0 · Cited by 155
A cohort study on mental disorders, stage of cancer at diagnosis and subsequent survival
Chang, C.-K., Hayes, R. D., Broadbent, M. T. M., Hotopf, M., Davies, E., Møller, H., & Stewart, R. (2014) · BMJ Open · doi:10.1136/bmjopen-2013-004295 · Cited by 133
Self-citationGold, P. W., Licinio, J., & Pavlatou, M. G. (2012) · Molecular Psychiatry · doi:10.1038/mp.2012.167 · Cited by 140
Treatment-resistant schizophrenia: current insights on the pharmacogenomics of antipsychotics
Lally, J., Gaughran, F., Timms, P., & Curran, S. (2016) · Pharmacogenomics and Personalized Medicine · doi:10.2147/pgpm.s115741 · Cited by 130
Innovative strategies for closing the mental health treatment gap globally
Rebello, T. J., Marques, A., Gureje, O., & Pike, K. M. (2014) · Current Opinion in Psychiatry · doi:10.1097/yco.0000000000000068 · Cited by 129
P2X7 Receptor Signaling in Stress and Depression
Ribeiro, D. E., Roncalho, A. L., Glaser, T., Ulrich, H., Wegener, G., & Joca, S. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20112778 · Cited by 129
“Moreover, the World Health Organization (WHO) expects depression to become the leading cause of disability worldwide in 2030 [6], being associated with an increased risk of all-cause mortality and a reduced life expectancy [7,8], thus representing a major contributor to the overall global burden of disease.”
BackgroundYildiz, A., Nikodem, M., Vieta, E., Correll, C. U., & Baldessarini, R. J. (2015) · Psychological Medicine · doi:10.1017/s0033291714001305 · Cited by 128
“…common in this population, but also from prevalent medical disorders with a consequent shortening in life expectancy of 10–13.6 years relative to the general population of same age (Ösby et al. 2001; Tondo et al. 2007; Chang et al. 2011; Laursen, 2011; Leboyer et al. 2012; Cipriani et al. 2013).”
BackgroundInfluentialHayes, R. D., Downs, J., Chang, C.-K., Jackson, R. G., Shetty, H., Broadbent, M., Hotopf, M., & Stewart, R. (2015) · Schizophrenia Bulletin · doi:10.1093/schbul/sbu120 · Cited by 128
Self-citationHolt, R. I. G., Gossage-Worrall, R., Hind, D., Bradburn, M. J., McCrone, P., Morris, T., Edwardson, C., Barnard, K., Carey, M. E., Davies, M. J., et al. (2019) · The British Journal of Psychiatry · doi:10.1192/bjp.2018.167 · Cited by 128
Hirdes, J. P., van Everdingen, C., Ferris, J., Franco-Martin, M., Fries, B. E., Heikkilä, J., Hirdes, A., Hoffman, R., James, M. L., Martin, L., et al. (2020) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2019.00926 · Cited by 124
“Aging is associated with the onset of a number of conditions that can affect mental health, with dementia as the most obvious example (29, 30).”
BackgroundContributions of specific causes of death to lost life expectancy in severe mental illness
Jayatilleke, N., Hayes, R. D., Dutta, R., Shetty, H., Hotopf, M., Chang, C.-K., & Stewart, R. (2017) · European Psychiatry · doi:10.1016/j.eurpsy.2017.02.487 · Cited by 111
“Estimated life expectancies for male and female cohort members in our analysis were comparable to those previously reported from the CRIS database [3].”
InfluentialSelf-citationMental health research in the Arab region: challenges and call for action
Maalouf, F. T., Alamiri, B., Atweh, S., Becker, A. E., Cheour, M., Darwish, H., Ghandour, L. A., Ghuloum, S., Hamze, M., Karam, E., et al. (2019) · The Lancet Psychiatry · doi:10.1016/s2215-0366(19)30124-5 · Cited by 109
Cardiovascular morbidity, mortality and pharmacotherapy in patients with schizophrenia
Lahti, M., Tiihonen, J., Wildgust, H., Beary, M., Hodgson, R., Kajantie, E., Osmond, C., Räikkönen, K., & Eriksson, J. (2012) · Psychological Medicine · doi:10.1017/s0033291712000396 · Cited by 107
“Patients suffering from schizophrenia lose up to 15–25 years of life compared with the general population (Hennekens et al. 2005 ; Kilbourne et al. 2009 ; Chang et al. 2011), mostly from natural causes.”
BackgroundSmoking and quitting behaviours by mental health conditions in Great Britain (1993–2014)
Richardson, S., McNeill, A. D., & Brose, L. S. (2018) · Addictive Behaviors · doi:10.1016/j.addbeh.2018.10.011 · Cited by 122
“There exist significant inequalities in health and life expectancy between individuals with mental health conditions and the general population (Chang et al., 2011; Chesney, Goodwin, & Fazel, 2014; Thornicroft, 2013) which have been estimated at up to 12.”
BackgroundCauses of mortality in schizophrenia: an updated review of European studies
Department of Psychiatry, W. M. U., Piotrowski, P., M. Gondek, T., Department of Psychiatry, W. M. U., Królicka-Deręgowska, A., Department of Psychiatry, W. M. U., Misiak, B., Department of Genetics, W. M. U., Adamowski, T., Department of Nervous System Diseases, F. O. H. S., et al. (2017) · Psychiatria Danubina · doi:10.24869/psyd.2017.108 · Cited by 107
“According to some studies (Laursen 2011, Laursen et al. 2013, Crump et al. 2013), also reduction in life expectancy in schizophrenia was significantly higher than British data, of 14.6 years for men and 9.8 years for women (Chang et al. 2011).”
ResultInfluentialPrice, A., Farooq, R., Yuan, J.-M., Menon, V. B., Cardinal, R. N., & O’Brien, J. T. (2017) · BMJ Open · doi:10.1136/bmjopen-2017-017504 · Cited by 102
Skonieczna-Żydecka, K., Łoniewski, I., Misera, A., Stachowska, E., Maciejewska, D., Marlicz, W., & Galling, B. (2019) · Psychopharmacology · doi:10.1007/s00213-018-5102-6 · Cited by 98
“Overall, in people with severe mental illness, life expectancy is shortened by 10–20 years (Chang et al. 2011), predominantly due to an imbalance in the cardiometabolic system.”
BackgroundJolley, S., Garety, P., Peters, E., Fornells-Ambrojo, M., Onwumere, J., Harris, V., Brabban, A., & Johns, L. (2015) · Behaviour Research and Therapy · doi:10.1016/j.brat.2014.11.006 · Cited by 97
“cost (Andrew, Knapp, McCrone, Parsonage, & Trachtenberg, 2012), with increased risk of physical health problems, and early mortality (Chang et al., 2011).”
BackgroundJaeschke, K. N., Hanna, F., Ali, S., Chowdhary, N., Dua, T., & Charlson, F. (2021) · Cambridge Prisms Global Mental Health · doi:10.1017/gmh.2021.19 · Cited by 124
“…on a 0.49 ratio derived from the literature (Kendler et al ., 1996; Widerlöv et al ., 1997; Cho et al ., 2007; Perala et al ., 2007; Perala et al ., 2008; Phillips et al ., 2009; Chang et al ., 2011; Binbay et al ., 2012; Jorgensen et al ., 2014; Moreno-Kustner et al ., 2016; Chang et al ., 2017).”
InfluentialMortality in treatment-resistant unipolar depression: A register-based cohort study in Sweden
Reutfors, J., Andersson, T. M.-L., Brenner, P., Brandt, L., DiBernardo, A., Li, G., Hägg, D., Wingård, L., & Bodén, R. (2018) · Journal of Affective Disorders · doi:10.1016/j.jad.2018.06.030 · Cited by 94
Biomarkers for bipolar disorder: current status and challenges ahead
Teixeira, A. L., Colpo, G. D., Fries, G. R., Bauer, I. E., & Selvaraj, S. (2019) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2019.1550361 · Cited by 94
“men and women with BD compared to the non-mentally ill general population, and these comorbidities seem to play a major role in this association [19].”
ResultRihmer, Z., & Döme, P. (2016) · Milestones in drug therapy · doi:10.1007/978-3-319-31689-5_4 · Cited by 94
Mangerud, W. L., Bjerkeset, O. A., Holmen, T. L., Lydersen, S., & Indredavik, M. S. (2014) · Journal of Adolescence · doi:10.1016/j.adolescence.2014.08.007 · Cited by 106
“These behaviors are closely related to increased morbidity and mortality and represent major public health challenges (Chang et al., 2011; Hale & Viner, 2012).”
BackgroundSerious mental illness and medical comorbidities: Findings from an integrated health care system
Bahorik, A. L., Satre, D. D., Kline‐Simon, A. H., Weisner, C. M., & Campbell, C. I. (2017) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2017.07.004 · Cited by 110
Silote, G. P., Sartim, A. G., Sales, A. J., Eskelund, A., Guimarães, F. S., Wegener, G., & Joca, S. R. L. (2019) · Journal of Chemical Neuroanatomy · doi:10.1016/j.jchemneu.2019.04.006 · Cited by 103
Lost Working Years Due to Mental Disorders: An Analysis of the Norwegian Disability Pension Registry
Knudsen, A. K., Øverland, S., Hotopf, M., & Mykletun, A. (2012) · PLoS ONE · doi:10.1371/journal.pone.0042567 · Cited by 93
Self-citationMismatch negativity (MMN) as biomarker predicting psychosis in clinically at-risk individuals
Näätänen, R., Todd, J., & Schall, U. (2015) · Biological Psychology · doi:10.1016/j.biopsycho.2015.10.010 · Cited by 98
Vitamin D deficiency in first episode psychosis: A case–control study
Crews, M., Lally, J., Gardner-Sood, P., Howes, O. D., Bonaccorso, S., Smith, S. M., Murray, R. M., Forti, M. D., & Gaughran, F. (2013) · Schizophrenia Research · doi:10.1016/j.schres.2013.08.036 · Cited by 97
“This is particularly so given that people with psychotic illnesses residing in the geographical area where this work was carried out have a life span shortened by up to 18 years (Chang et al., 2011).”
A controlled trial of mental illness related stigma training for medical students
Kassam, A., Glozier, N., Leese, M., Loughran, J., & Thornicroft, G. (2011) · BMC Medical Education · doi:10.1186/1472-6920-11-51 · Cited by 89
“5 years of life through earlier mortality [35] and that access to life saving interventions is poorer for those with mental illness [16] such educational initiatives would seem a prerequisite of good medical education.”
BackgroundAchieving Smoke-Free Mental Health Services: Lessons from the Past Decade of Implementation Research
Lawn, S., & Campion, J. (2013) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph10094224 · Cited by 99
Kraguljac, N. V., Guerreri, M., Strickland, M. J., & Zhang, H. G. (2022) · Biological Psychiatry Global Open Science · doi:10.1016/j.bpsgos.2021.12.012 · Cited by 82
“The negative effects of these disorders are not only apparent for a patient’s well-being and quality of life (3), they are also expressed through reduced life expectancy and increased mortality (4,5).”
BackgroundSchneider-Thoma, J., Efthimiou, O., Huhn, M., Krause, M., Reichelt, L., Röder, H., Davis, J. M., Salanti, G., & Leucht, S. (2018) · The Lancet Psychiatry · doi:10.1016/s2215-0366(18)30177-9 · Cited by 81
Heiberg, I. H., Jacobsen, B. K., Nesvåg, R., Bramness, J. G., Reichborn‐Kjennerud, T., Næss, Ø., Ystrøm, E., Hultman, C. M., & Høye, A. (2018) · PLoS ONE · doi:10.1371/journal.pone.0202028 · Cited by 108
Jia, H., Zack, M. M., Thompson, W. W., Crosby, A. E., & Gottesman, I. I. (2015) · Social Psychiatry and Psychiatric Epidemiology · doi:10.1007/s00127-015-1019-0 · Cited by 81
“Depression can be life threatening and has been associated with excess mortality and substantially lower life expectancy [10, 11].”
Staudt Hansen, P., Frahm Laursen, M., Grøntved, S., Puggard Vogt Straszek, S., Licht, R. W., & Nielsen, R. E. (2019) · Bipolar Disorders · doi:10.1111/bdi.12684 · Cited by 80
Depp, C. A., Bowie, C. R., Mausbach, B. T., Wolyniec, P., Thornquist, M. H., Luke, J. R., McGrath, J. A., Pulver, A. E., Patterson, T. L., & Harvey, P. D. (2015) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.12380 · Cited by 79
“On the one hand, higher rates of smoking are attributed to the greatly elevated rates of cardiovascular morbidity and mortality among patients with SMI, which occurs approximately 10–25 years earlier than that in healthy comparators (5).”
BackgroundStrategies for Successful Aging: A Research Update
Harmell, A. L., Jeste, D. V., & Depp, C. A. (2014) · Current Psychiatry Reports · doi:10.1007/s11920-014-0476-6 · Cited by 102
Wu, C.-Y., Chang, C.-K., Robson, D., Jackson, R., Chen, S.-J., Hayes, R. D., & Stewart, R. (2013) · PLoS ONE · doi:10.1371/journal.pone.0074262 · Cited by 78
“The SLaM Case Register was established in 2006 and has been used for a range of research projects focusing on SMI and its consequences [18-22] with a robust de-identification program [22].”
MethodSelf-citationEnvejecimiento activo y de éxito o saludable: una breve historia de modelos conceptuales
Петретто, Д. Р., Pili, R., Gaviano, L., López, C. M., & Zuddas, C. (2016) · Revista Española de Geriatría y Gerontología · doi:10.1016/j.regg.2015.10.003 · Cited by 190
“…éxito llevada a cabo por Har-mell et al. (2014), refiriéndose tanto a ancianos con trastornos psiquiátricos como a ancianos sin ellos 36 Los autores se˜nalan que diversas enfermedades psiquiátricas tienden a acelerar el envejecimiento, por ejemplo, la esquizofrenia o los trastornos bipolares 37,38 .”
BackgroundPatel, R., Shetty, H., Jackson, R., Broadbent, M., Stewart, R., Boydell, J., McGuire, P., & Taylor, M. (2015) · PLOS ONE · doi:10.1371/journal.pone.0126530 · Cited by 75
Self-citationBaxter, A. J., Harris, M., Khatib, Y., Brugha, T. S., Bien, H., & Bhui, K. S. (2016) · The British Journal of Psychiatry · doi:10.1192/bjp.bp.115.163170 · Cited by 91
“earlier than those without mental disorders.(1) This life expectancy gap is increasing.”
Ratliff, J. C., Palmese, L. B., Reutenauer, E. L., Srihari, V. H., & Tek, C. (2013) · Psychosomatics · doi:10.1016/j.psym.2012.03.001 · Cited by 71
“Schizophrenia patients have a life expectancy that is approximately two decades shorter than the general population, along with high rates of CVD mortality (7, 8).”
BackgroundReporting of clinically diagnosed dementia on death certificates: retrospective cohort study
Perera, G., Stewart, R., Higginson, I. J., & Sleeman, K. E. (2016) · Age and Ageing · doi:10.1093/ageing/afw077 · Cited by 68
“This data resource has been described in detail [14, 15] and has supported a range of analyses [16–18].”
MethodSelf-citationFunctional Status and All-Cause Mortality in Serious Mental Illness
Hayes, R. D., Chang, C., Fernandes, A. C., Begum, A., To, D., Broadbent, M. T. M., Hotopf, M. H., & Stewart, R. J. (2012) · PLoS ONE · doi:10.1371/journal.pone.0044613 · Cited by 72
Self-citationTaylor, G. M. J., Itani, T., Thomas, K. H., Rai, D., Jones, T., Windmeijer, F., Martin, R. M., Munafò, M. R., Davies, N. M., & Taylor, A. E. (2020) · Nicotine & Tobacco Research · doi:10.1093/ntr/ntz072 · Cited by 68
Association of ECT With Risks of All-Cause Mortality and Suicide in Older Medicare Patients
Rhee, T. G., Sint, K., Olfson, M., Gerhard, T., Busch, S. H., & Wilkinson, S. T. (2021) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2021.21040351 · Cited by 70
Life years lost among patients with a given disease: P. K. ANDERSEN
Andersen, P. K. (2017) · Statistics in Medicine · doi:10.1002/sim.7357 · Cited by 68
“Nevertheless, such numbers were presented in [2, 12] in the form of life expectancies at birth for patients with different psychiatric disorders.”
BackgroundMethodPerera, G., Khondoker, M., Broadbent, M., Breen, G., & Stewart, R. (2014) · PLoS ONE · doi:10.1371/journal.pone.0109484 · Cited by 67
Self-citationGreen, S., Beveridge, E., Evans, L., Trite, J., Jayacodi, S., Evered, R., Parker, C., Polledri, L., Tabb, E., Green, J., et al. (2018) · International Journal of Mental Health Systems · doi:10.1186/s13033-018-0179-1 · Cited by 67
“Background In the UK, life expectancy for people living with a serious mental illness (SMI), such as schizophrenia and bipolar disorder, is reduced by 15–20 years compared with the general population [1, 2].”
BackgroundMelo, A. P. S., Dippenaar, I. N., Johnson, S. C., Weaver, N. D., de Assis Acurcio, F., Malta, D. C., Ribeiro, A. L. P., Júnior, A. A. G., Wool, E. E., Naghavi, M., et al. (2022) · The Lancet Psychiatry · doi:10.1016/s2215-0366(22)00237-1 · Cited by 66
Sleeman, K. E., Perera, G., Stewart, R. J., & Higginson, I. J. (2017) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2017.06.2267 · Cited by 78
Self-citationChan, J. K. N., Wong, C. S. M., Yung, N. C. L., Chen, E. Y. H., & Chang, W. C. (2021) · Epidemiology and Psychiatric Sciences · doi:10.1017/s2045796021000305 · Cited by 69
“Of note, although we affirmed that bipolar disorder was associated with considerably shortened life expectancy after diagnosis, our observed magnitude of longevity gap is smaller than most previous estimates based on YLLs, ranging between 10 and 15 years shorter in lifespan than the general population (Chang et al., 2…”
BackgroundResultInfluentialNitric oxide signalling and antidepressant action revisited
Joca, S. R. L., Sartim, A. G., Roncalho, A. L., Diniz, C. F. A., & Wegener, G. (2019) · Cell and Tissue Research · doi:10.1007/s00441-018-02987-4 · Cited by 63
Jacobs, R., Gutacker, N., Mason, A., Goddard, M. K., Gravelle, H. S. E., Kendrick, T., & Gilbody, S. M. (2015) · BMC Health Services Research · doi:10.1186/s12913-015-1107-6 · Cited by 78
“This paper examines the key patient and local area determinants of inpatient length of stay (LOS) for patients with a main diagnosis of SMI and examines the variation in LOS between hospital providers in England.”
BackgroundInfluentialOlin, B., Jayewardene, A. K., Bunker, M., & Moreno, F. (2012) · PLoS ONE · doi:10.1371/journal.pone.0048002 · Cited by 63
“A study in the United Kingdom observed that the average decrease in life expectancy for patients with recurrent major depressive disorder is 7 years lost for females and almost 11 years lost for males [9].”
BackgroundMortality and Its Determinants in People With Psychotic Disorder
Suvisaari, J., Partti, K., Perälä, J., Viertiö, S., Saarni, S. E., Lönnqvist, J., Saarni, S. I., & Härkänen, T. (2013) · Psychosomatic Medicine · doi:10.1097/psy.0b013e31827ad512 · Cited by 63
“Previous studies have reported elevated mortality in schizoaffective disorder (3,40), whereas ONAP have been studied much less.”
BackgroundShared goals for mental health research: what, why and when for the 2020s
Wykes, T., Bell, A., Carr, S., Coldham, T., Gilbody, S. M., Hotopf, M. H., Johnson, S., Kabir, T., Pinfold, V., Sweeney, A., et al. (2021) · Journal of Mental Health · doi:10.1080/09638237.2021.1898552 · Cited by 71
“They are over three times more likely to have a physical health problem and may die 10 – 20 years earlier than others in the general population (Chang et al., 2011).”
BackgroundSelf-citation
Metadata
- Authors
- Chang, C.-K., Hayes, R. D., Perera, G., Broadbent, M. T. M., Fernandes, A. C., Lee, W. E., Hotopf, M., & Stewart, R.
- Affiliations
- King's College London (GB)
- South London and Maudsley NHS Foundation Trust (GB)
- Corresponding author
- Chang, Chin-Kuo
- ORCID
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2011-05-18
- Volume
- 6
- Issue
- 5
- Pages
- e19590
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC3097201
- OpenAlex
- W2010135111
- Cited by
- 714
- References
- 44
- Citations by year
- 2026: 17 · 2025: 38 · 2024: 42 · 2023: 45 · 2022: 68 · 2021: 54 · 2020: 62 · 2019: 53 · 2018: 54 · 2017: 46 · 2016: 65 · 2015: 50 · 2014: 52 · 2013: 38 · 2012: 24
- FWCI
- 51.28
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS ONE (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Research Portal (King's College London) (submittedVersion, other-oa)
- Funders
- South London and Maudsley NHS Foundation Trust
- National Institute for Health and Care Research
- King's College London
- Medical Research Council
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Mental Health Treatment and Access
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Social Sciences › Psychology › Clinical Psychology › Suicide and Self-Harm Studies
- Keywords
- life expectancy at birth, severe mental illness, mortality gap, premature mortality, schizophrenia, schizoaffective disorder, bipolar disorder, substance use disorders, depressive disorders, years of life lost, sex differences, secondary mental health care, South London and Maudsley NHS Foundation Trust
- MeSH terms
- Adolescent, Adult, Aged, Mental Disorders, Demography, Female, Humans, Life Expectancy, London, Male, Mental Health, Middle Aged, Registries, Wales, Age Distribution, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-11, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-11 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
